Mitsuyasu Rt
- Virology top 5%
- HIV Research and Treatment 3
- Hematology top 10%
- Blood groups and transfusion 3
-
- HIV/AIDS drug development and treatment 3
-
- Viral-associated cancers and disorders 3
-
- Immunodeficiency and Autoimmune Disorders 4
-
- Chronic Lymphocytic Leukemia Research 3
-
- Erythrocyte Function and Pathophysiology 2
-
- Lymphoma Diagnosis and Treatment 2
- Journals
- Blood (5 papers)AIDS Research and Treatment (1 paper)PubMed (6 papers)
- Partner nations
- United StatesGeorgiaIndia
In The Last Decade
Mitsuyasu Rt
12 papers receiving 332 citations
Peers
Comparison fields: 5 of 47
- Virology 121
- Hematology 84
- Infectious Diseases 111
- Oncology 149
- Immunology 76
Countries citing papers authored by Mitsuyasu Rt
This map shows the geographic impact of Mitsuyasu Rt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuyasu Rt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuyasu Rt more than expected).
Fields of papers citing papers by Mitsuyasu Rt
This network shows the impact of papers produced by Mitsuyasu Rt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuyasu Rt. The network helps show where Mitsuyasu Rt may publish in the future.
Co-authorship network
The 21 scholars most cited alongside Mitsuyasu Rt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 19 | |
| 2 | AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma. | 1997 | 11 |
| 3 | Phenotypically defined memory CD4+ cells are not selectively decreased in chronic HIV disease. | 1994 | 28 |
| 4 | Clinical uses of hematopoietic growth hormones in HIV-related illnesses. | 1993 | 9 |
| 5 | 1991 | 28 | |
| 6 | Syngeneic bone-marrow transplantation and failure to eradicate HIV. | 1991 | 13 |
| 7 | 1991 | 110 | |
| 8 | 1991 | 5 | |
| 9 | 1990 | 2 | |
| 10 | 1990 | 44 | |
| 11 | Biotherapy with interferon in AIDS-related Kaposi's sarcoma. | 1988 | 1 |
| 12 | Biology and therapy of Kaposi's sarcoma. | 1984 | 79 |
About Mitsuyasu Rt
Mitsuyasu Rt is a scholar working on Virology, Hematology and Genetics, having authored 12 papers that have together received 349 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (4 papers), HIV Research and Treatment (3 papers), Viral-associated cancers and disorders (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Blood groups and transfusion (3 papers), HIV/AIDS drug development and treatment (3 papers), Erythrocyte Function and Pathophysiology (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Virology (121 citations), Hematology (84 citations) and Infectious Diseases (111 citations). Mitsuyasu Rt has collaborated with scholars based in United States, Georgia and India. Frequent co-authors include J Moreno, Glaspy Ja, Gayle Cocita Baldwin, N. Kirby Alton, L Souza, L Souza, KM Zsebo, Roger Detels, S O'Rourke and J. C. Samantaray. Their work appears in journals such as Blood, AIDS Research and Treatment and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.